Further structure-activity relationship studies on 4-((((3S,6S)-6-benzhydryltetrahydro-2H-pyran-3-yl)amino)methyl)phenol: identification of compounds with triple uptake inhibitory activity as potential antidepressant agents.
Further structure-activity relationship studies on 4-((((3S,6S)-6-benzhydryltetrahydro-2H-pyran-3-yl)amino)methyl)phenol: identification of compounds with triple uptake inhibitory activity as potential antidepressant agents.
复制标题
DOI:
10.1021/jm200020a
复制
发表时间:
2011-04-28
影响因子:
7.3
通讯作者:
Dutta, Aloke
中科院分区:
文献类型:
--
作者:
Gopishetty, Bhaskar;Hazeldine, Stuart;Santra, Soumava;Johnson, Mark;Modi, Gyan;Ali, Solav;Zhen, Juan;Reith, Maarten;Dutta, Aloke
To investigate structural alterations of the lead triple uptake inhibitor molecule, disubstituted 4-((((3S,6S)-6-benzhydryltetrahydro-2H-pyran-3-yl)amino)methyl)phenol, we have carried out structure-activity relationship (SAR) studies to investigate the effect of alteration of aromatic substitutions and introduction of heterocyclic aromatic moieties on this molecular template. The novel compounds were tested for their affinities for the dopamine transporter (DAT), serotonin transporter (SERT), and norepinephrine transporter (NET) in the brain by measuring their potency in inhibiting the uptake of [3H]DA, [3H]5-HT, and [3H]NE, respectively. SAR results indicate dopamine norepinephrine reuptake inhibitory (DNRI) type activity in thiophene (10g) and pyrrole (10i) derivatives. On the other hand, 3-hydroxy phenyl derivative 10f and 4-methoxy phenyl derivative 10j exhibited a triple reuptake inhibitory (TUI) activity profile as these molecules exhibited potent uptake inhibition for all the monoamine transporters (Ki; 31.3, 40, 38.5 and 15.9, 12.9, 29.3 for DAT, SERT and NET, for 10f and 10g respectively). Compound 10f was further evaluated in the rat forced swim test to evaluate its potential antidepressant effect. The results show significant reduction of immobility by TUI 10f at 10 mg/kg dose, indicating potential antidepressant activity.
登录
查看更多内容
影响因子:
7.3
作者:
Kolhatkar, R;Cook, CD;Dutta, AK
通讯作者:
Dutta, AK
DOI:
10.1111/j.1527-3458.2006.00123.x
发表时间:
2006-06-01
期刊:
CNS DRUG REVIEWS
影响因子:
--
作者:
Skolnick, Phil;Krieter, Philip;Lippa, Arnold
通讯作者:
Lippa, Arnold
影响因子:
7.3
作者:
Ghorai, SK;Cook, C;Dutta, AK
通讯作者:
Dutta, AK
影响因子:
2.7
作者:
Dutta, AK;Davis, MC;Reith, MEA
通讯作者:
Reith, MEA
影响因子:
7.3
作者:
Dutta, AK;Davis, MC;Reith, MEA
通讯作者:
Reith, MEA